Rendered visual concept — not inventory photography. Label text in imagery is decorative.
Metabolic
GLP-1 (7-37)
Currently unavailable
Glucagon-like peptide-1 (7-37), native fragment
Strength
5 mg
Vial count
Unspecified
Strength of evidence
Early human studies
Research summary
Endogenous incretin fragment used as a reference ligand in receptor and physiology research; very short half-life.
Regulatory status
Research reagent only. Not approved as a drug.
No certificate of analysis or purity figure is shown because none has been verified for this demo. No dosing information is provided.
Information only. Purchases and payments are disabled.
Regulatory notice (Canada): Labelling a product “for research use only” does not make it legal to sell unapproved injectable peptides. In Canada, drugs for human use require Health Canada authorization. This site is a non-transactional design demo: nothing is for sale, and nothing here is medical advice or dosing guidance.